Back to top
more

Edwards Lifesciences (EW)

(Delayed Data from NYSE)

$70.27 USD

70.27
5,424,803

+1.80 (2.63%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $70.26 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (88 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Edwards Lifesciences (EW) Beats on Q1 Earnings, Cuts '20 View

Amid the coronavirus impact on sales, Edwards Lifesciences (EW) witnesses growth in TAVR procedures led by strong therapy adoption across all geographies, particularly in the United States.

Mark Vickery headshot

Intel, Edwards Lifesciences Top Q1 Earnings Estimates

The chipmaker giant and the MedTech company both outperformed expectations in their Q1 earnings reports.

Edwards Lifesciences (EW) Q1 Earnings and Revenues Top Estimates

Edwards Lifesciences (EW) delivered earnings and revenue surprises of 17.05% and 7.64%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Can TAVR's SAPIEN 3 Aid Edwards Lifesciences (EW) Q1 Earnings?

Robust customer adoption of the HemoSphere all-in-one monitoring platform and TAVR treatments is likely to have driven Edwards Lifesciences' (EW) Q1 revenues.

Edwards Lifesciences (EW) Outpaces Stock Market Gains: What You Should Know

Edwards Lifesciences (EW) closed the most recent trading day at $217.52, moving +1.34% from the previous trading session.

Edwards Lifesciences (EW) Earnings Expected to Grow: Should You Buy?

Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Kevin Cook headshot

Bull of the Day: Penumbra (PEN)

This $5 billion innovator removes blood clots and the deadly shadow of stroke with catheter-based aspiration technologies

Edwards Lifesciences (EW) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Edwards Lifesciences (EW) closed at $194.73, marking a -0.35% move from the previous day.

Edwards Lifesciences, The Trade Desk, Blue Apron, Domino's Pizza and Grubhub highlighted as Zacks Bull and Bear of the Day

Edwards Lifesciences, The Trade Desk, Blue Apron, Domino's Pizza and Grubhub highlighted as Zacks Bull and Bear of the Day

Zacks Value Trader Highlights: eBay, Pfizer, JPMorgan Chase, Intuitive Surgical and Edwards Lifesciences

Zacks Value Trader Highlights: eBay, Pfizer, JPMorgan Chase, Intuitive Surgical and Edwards Lifesciences

Kevin Cook headshot

Bull of the Day: Edwards Lifesciences (EW)

While most elective procedures are being deferred, the innovator of minimally-invasive heart valve replacement beats on

Tracey Ryniec headshot

5 Superstar Stocks on Sale During the Coronavirus Crisis

Stocks are the only thing people won't buy when they go on sale. But with stocks in a bear market, now's your chance to pick up some of the best companies.

Medtronic Demonstrates All-Line Growth Despite Cost Concerns

Major business lines of Medtronic (MDT) register stellar growth across all customer groups and geographies in Q3.

Here's Why You Should Buy Edwards Lifesciences Stock Now

Investor confidence is high in Edwards Lifesciences (EW) stock, courtesy of solid prospects.

Why Is Edwards Lifesciences (EW) Down 12.5% Since Last Earnings Report?

Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Edwards Lifesciences (EW) Stock Might be a Great Pick

Edwards Lifesciences (EW) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Urmimala Biswas headshot

Medical Products Stock Q4 Earnings on Feb 13: DXCM, LH & More

Strong foothold in the emerging markets so far widely contributes to some of the industry players' Q4 results.

The Zacks Analyst Blog Highlights: Exxon Mobil, Chevron, IBM, Gilead and Edwards Lifesciences

The Zacks Analyst Blog Highlights: Exxon Mobil, Chevron, IBM, Gilead and Edwards Lifesciences

Sheraz Mian headshot

Coronavirus Starting to Weigh on 2020 Q1 Earnings Estimates

In addition to featuring fresh research reports on Exxon (XOM), Chevron (CVX), IBM (IBM) and others, today's Research Daily provides the Q4 earnings season update.

Edwards Lifesciences (EW) Q4 Earnings Lag, Sales Top Estimates

Edwards Lifesciences (EW) witnesses growth in TAVR procedures, led by strong therapy adoption across all geographies, particularly in the United States.

Edwards Lifesciences (EW) Misses Q4 Earnings Estimates

Edwards Lifesciences (EW) delivered earnings and revenue surprises of -1.35% and 1.71%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Tracey Ryniec headshot

5 Top Non-Tech Earnings Charts

It's not all about technology or social media companies. These 5 companies are also in the earnings spotlight.

Medical Products' Jan 30 Earnings Roster: TMO, EW & More

Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have contributed to the performance of the players in the medical products space this earnings season.

Why Edwards Lifesciences (EW) Could Beat Earnings Estimates Again

Edwards Lifesciences (EW) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Urmimala Biswas headshot

Medical Products' Earnings Due on Jan 29: ALGN, HOLX & More

A series of product launches despite the ongoing regulatory hurdles is likely to favor revenues in the medical products space this earnings season.